$NWBO
NORTHWEST BIOTHERAPEUTICS INC Stock $nwbo

$nwbo Overview Financials Valuation SEC Filings Company Website

2016 Q4 Form 10-K Financial Statement

#000114420417020754 Filed on April 17, 2017

Income Statement

Concept	2016 Q4	2015 Q4	2015
Revenue	$70.00K	$863.0K	$1.739M
YoY Change	-91.89%	-1.03%	19.6%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$4.490M	$7.440M	$24.90M
YoY Change	-39.65%	41.98%	46.93%
% of Gross Profit
Research & Development	$16.83M	$44.81M	$103.1M
YoY Change	-62.44%	109.39%	20.42%
% of Gross Profit
Depreciation & Amortization	$50.00K	$20.00K	$56.00K
YoY Change	150.0%	-105.88%	366.67%
% of Gross Profit
Operating Expenses	$21.32M	$52.25M	$103.1M
YoY Change	-59.2%	96.13%	20.42%
Operating Profit			-$126.3M
YoY Change			24.86%
Interest Expense	-$3.060M	$27.31M	$4.153M
YoY Change	-111.2%	-257.77%	316.97%
% of Operating Profit
Other Income/Expense, Net	$0.00	$27.31M	$0.00
YoY Change	-100.0%	-258.22%	-100.0%
Pretax Income	-$30.71M	-$24.08M	-$114.7M
YoY Change	27.53%	-43.59%	-15.4%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$30.71M	-$24.08M	-$114.7M
YoY Change	27.54%	-43.59%	-15.4%
Net Earnings / Revenue	-43871.43%	-2790.03%	-6598.1%
Basic Earnings Per Share		-$0.27
Diluted Earnings Per Share	-$240.3K	-$0.27	-$1.476M
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2016 Q4	2015 Q4	2015
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.190M	$21.81M	$21.81M
YoY Change	-71.62%	62.88%	62.91%
Cash & Equivalents	$6.871M	$21.81M	$21.81M
Short-Term Investments
Other Short-Term Assets	$1.700M	$2.290M	$2.288M
YoY Change	-25.76%	81.75%	491.21%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$7.884M	$24.10M	$24.10M
YoY Change	-67.29%	64.6%	64.6%
LONG-TERM ASSETS
Property, Plant & Equipment	$315.0K	$476.0K	$46.16M
YoY Change	-33.82%	-98.81%	15.4%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$148.0K	$190.0K	$539.0K
YoY Change	-22.11%	245.45%	-70.3%
Total Long-Term Assets	$45.02M	$46.70M	$46.70M
YoY Change	-3.58%	11.68%	11.68%
TOTAL ASSETS
Total Short-Term Assets	$7.884M	$24.10M	$24.10M
Total Long-Term Assets	$45.02M	$46.70M	$46.70M
Total Assets	$52.91M	$70.80M	$70.80M
YoY Change	-25.27%	25.4%	25.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$12.38M	$11.72M	$17.18M
YoY Change	5.61%	19.29%
Accrued Expenses	$901.0K	$1.309M	$1.309M
YoY Change	-31.17%	8.09%
Deferred Revenue
YoY Change
Short-Term Debt	$2.760M	$930.0K	$934.0K
YoY Change	196.77%	0.0%	0.0%
Long-Term Debt Due	$20.75M	$11.33M	$11.33M
YoY Change	83.14%	77.86%	77.96%
Total Short-Term Liabilities	$76.41M	$64.79M	$64.93M
YoY Change	17.93%	-13.62%	-13.44%
LONG-TERM LIABILITIES
Long-Term Debt	$3.000M	$10.54M	$10.54M
YoY Change	-71.54%	-35.65%	-35.62%
Other Long-Term Liabilities		$141.0K
YoY Change		43.88%
Total Long-Term Liabilities	$3.000M	$10.54M	$10.54M
YoY Change	-71.55%	-36.01%	-35.62%
TOTAL LIABILITIES
Total Short-Term Liabilities	$76.41M	$64.79M	$64.93M
Total Long-Term Liabilities	$3.000M	$10.54M	$10.54M
Total Liabilities	$79.41M	$75.47M	$75.47M
YoY Change	5.21%	-17.5%	-17.5%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$687.1M	$630.7M
YoY Change	8.95%	29.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$26.50M	-$4.676M	-$4.676M
YoY Change
Total Liabilities & Shareholders Equity	$52.91M	$70.80M	$70.80M
YoY Change	-25.27%	25.4%	25.4%

Cashflow Statement

Concept	2016 Q4	2015 Q4	2015
OPERATING ACTIVITIES
Net Income	-$30.71M	-$24.08M	-$114.7M
YoY Change	27.54%	-43.59%	-15.4%
Depreciation, Depletion And Amortization	$50.00K	$20.00K	$56.00K
YoY Change	150.0%	-105.88%	366.67%
Cash From Operating Activities	-$14.09M	-$23.23M	-$78.61M
YoY Change	-39.35%	24.89%	44.03%
INVESTING ACTIVITIES
Capital Expenditures	-$170.0K	-$2.740M	-$6.751M
YoY Change	-93.8%	-75.96%	-79.98%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$170.0K	-$2.740M	-$6.751M
YoY Change	-93.8%	-75.94%	-81.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	17.49M	41.37M	$94.24M
YoY Change	-57.72%	-1.45%	9.81%
NET CHANGE
Cash From Operating Activities	-14.09M	-23.23M	-$78.61M
Cash From Investing Activities	-170.0K	-2.740M	-$6.751M
Cash From Financing Activities	17.49M	41.37M	$94.24M
Net Change In Cash	3.230M	15.40M	$8.879M
YoY Change	-79.03%	28.44%	-273.79%
FREE CASH FLOW
Cash From Operating Activities	-$14.09M	-$23.23M	-$78.61M
Capital Expenditures	-$170.0K	-$2.740M	-$6.751M
Free Cash Flow	-$13.92M	-$20.49M	-$71.86M
YoY Change	-32.06%	184.58%	244.65%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-123000	USD
CY2015Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	10543000	USD
CY2016Q4	nwbo	Development Stage Enterprise Deficit Accumulated During Development Stage1 DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage1	715476000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1848000	USD
CY2016Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	9791000	USD
CY2015Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	11144000	USD
CY2016	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10867000	USD
CY2016Q4	us-gaap	Accrued Environmental Loss Contingencies Current AccruedEnvironmentalLossContingenciesCurrent	6200000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	315000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	476000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21813000	USD
CY2016Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	685000	USD
CY2015Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	886000	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1402000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	24101000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6186000	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1013000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	7884000	USD
CY2016Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	0	USD
CY2015Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	349000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	148000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	190000	USD
CY2016Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	45022000	USD
CY2015Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	46696000	USD
CY2016Q4	us-gaap	Assets Assets	52906000	USD
CY2015Q4	us-gaap	Assets Assets	70797000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	12378000	USD
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	11721000	USD
CY2016Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3000000	USD
CY2016	us-gaap	Sales Revenue Net SalesRevenueNet	623000	USD
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	60081000	USD
CY2015	us-gaap	Revenue From Grants RevenueFromGrants	1739000	USD
CY2015	us-gaap	Sales Revenue Net SalesRevenueNet	1739000	USD
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	103120000	USD
CY2015	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	18326000	USD
CY2015	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	128023000	USD
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	-126284000	USD
CY2015	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	15676000	USD
CY2015	us-gaap	Interest Expense InterestExpense	4153000	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	-114741000	USD
CY2015	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	20000	USD
CY2016	us-gaap	Revenue From Grants RevenueFromGrants	623000	USD
CY2016	nwbo	Value Of Warrants Exercised For Cash ValueOfWarrantsExercisedForCash	8066000	USD
CY2016	nwbo	Deemed Dividend Related To Warrant Modification DeemedDividendRelatedToWarrantModification	5647000	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	-79266000	USD
CY2016	us-gaap	Interest Expense InterestExpense	3818000	USD
CY2016	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-6732000	USD
CY2016Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	23353000	USD
CY2015Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	5455000	USD
CY2016Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	10960000	USD
CY2015Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	135000	USD
CY2016Q4	us-gaap	Notes Payable Current NotesPayableCurrent	0	USD
CY2015Q4	us-gaap	Notes Payable Current NotesPayableCurrent	934000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	901000	USD
CY2015Q4	us-gaap	Accrued Environmental Loss Contingencies Current AccruedEnvironmentalLossContingenciesCurrent	6200000	USD
CY2015Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	27982000	USD
CY2016Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	0	USD
CY2015Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	10543000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	79405000	USD
CY2016	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	17891000	USD
CY2015	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2016	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	79889000	USD
CY2016	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	1037000	USD
CY2016	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	17899000	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-55652000	USD
CY2016	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	4939000	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-4939000	USD
CY2016	nwbo	Stock And Warrants Issued To Related Party Expenses StockAndWarrantsIssuedToRelatedPartyExpenses	13654000	USD
CY2016	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	0	USD
CY2016	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-80214000	USD
CY2015	nwbo	Deemed Dividend Related To Warrant Modification DeemedDividendRelatedToWarrantModification	0	USD
CY2016	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1152000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-67000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-1971000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-114674000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-78243000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1971000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	1877000	USD
CY2016	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	19987000	USD
CY2016	nwbo	Adjustments To Additional Paid In Capital Modification On Warrant Exercise Price AdjustmentsToAdditionalPaidInCapitalModificationOnWarrantExercisePrice	5647000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	5647000	USD
CY2016	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	127000	USD
CY2016	nwbo	Adjustments To Additional Paid In Capitaloffering Cost Related To Warrants Exercise AdjustmentsToAdditionalPaidInCapitalofferingCostRelatedToWarrantsExercise	795000	USD
CY2016	nwbo	Stock And Warrants Issued During Period Value Private Placement Net Of Offering Costs StockAndWarrantsIssuedDuringPeriodValuePrivatePlacementNetOfOfferingCosts	2206000	USD
CY2016	nwbo	Adjustments To Additional Paid In Capital Reclassification AdjustmentsToAdditionalPaidInCapitalReclassification	1872000	USD
CY2016	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	0	USD
CY2016	nwbo	Adjustment To Additional Paidup Capital Extinguishment Of Shares Payable AdjustmentToAdditionalPaidupCapitalExtinguishmentOfSharesPayable	22539000	USD
CY2016	nwbo	Adjustment To Additional Paidup Capital Extinguishment Of Derivate Liability AdjustmentToAdditionalPaidupCapitalExtinguishmentOfDerivateLiability	10131000	USD
CY2016	nwbo	Stock And Warrants Issued During Period Value Conversion Of Debt And Accrued Interest StockAndWarrantsIssuedDuringPeriodValueConversionOfDebtAndAccruedInterest	3021000	USD
CY2015	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	2809000	USD
CY2015	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	3048000	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-79711000	USD
CY2015	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	6751000	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-6751000	USD
CY2015	nwbo	Stock And Warrants Issued To Related Party Expenses StockAndWarrantsIssuedToRelatedPartyExpenses	40765000	USD
CY2015	nwbo	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	478000	USD
CY2015	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	4997000	USD
CY2015	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	138000	USD
CY2015	us-gaap	Depreciation And Amortization DepreciationAndAmortization	56000	USD
CY2016	us-gaap	Depreciation And Amortization DepreciationAndAmortization	189000	USD
CY2015	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1248000	USD
CY2016	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	850000	USD
CY2016	nwbo	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	-42000	USD
CY2015	nwbo	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	135000	USD
CY2015	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	7430000	USD
CY2016	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	8066000	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	38308000	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	93951000	USD
CY2016	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	6106000	USD
CY2015	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-456000	USD
CY2016	nwbo	Proceeds From Issuance Of Capital Stock And Warrants ProceedsFromIssuanceOfCapitalStockAndWarrants	19987000	USD
CY2015	nwbo	Proceeds From Issuance Of Capital Stock And Warrants ProceedsFromIssuanceOfCapitalStockAndWarrants	81662000	USD
CY2016	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1077000	USD
CY2015	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	127000	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	3389000	USD
CY2016	nwbo	Payment Of Warrants Excercise Offering Cost PaymentOfWarrantsExcerciseOfferingCost	795000	USD
CY2015	nwbo	Payment Of Warrants Excercise Offering Cost PaymentOfWarrantsExcerciseOfferingCost	0	USD
CY2016	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	6417000	USD
CY2015	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	USD
CY2016Q4	us-gaap	Accrued Environmental Loss Contingencies Noncurrent AccruedEnvironmentalLossContingenciesNoncurrent	6200000	USD
CY2016	us-gaap	Site Contingency Loss Exposure In Excess Of Accrual Best Estimate SiteContingencyLossExposureInExcessOfAccrualBestEstimate	6200000	USD
CY2016Q3	nwbo	Class Of Warrants Or Rights Warrants Issued ClassOfWarrantsOrRightsWarrantsIssued	6880574	shares
CY2016Q3	nwbo	Class Of Warrants Or Rights Replacement Warrants Issued ClassOfWarrantsOrRightsReplacementWarrantsIssued	4305772	shares
CY2016	nwbo	Class Of Warrants Or Rights Warrants Exercised For Cash ClassOfWarrantsOrRightsWarrantsExercisedForCash	2555000	shares
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	405000	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	216000	USD
CY2016	us-gaap	Depreciation Depreciation	189000	USD
CY2015	us-gaap	Depreciation Depreciation	56000	USD
CY2015Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	23731000	USD
CY2015Q4	us-gaap	Long Term Debt LongTermDebt	22806000	USD
CY2016Q4	us-gaap	Shortterm Debt Fair Value ShorttermDebtFairValue	5200000	USD
CY2015Q4	us-gaap	Shortterm Debt Fair Value ShorttermDebtFairValue	0	USD
CY2016Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	2760000	USD
CY2015Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	50000	USD
CY2016Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	3000000	USD
CY2015Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	0	USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	nwbo	Accrued Expenses Related Party AccruedExpensesRelatedParty	40000	USD
CY2015Q4	nwbo	Accrued Expenses Related Party AccruedExpensesRelatedParty	11000	USD
CY2016Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	310000	USD
CY2015Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	50000	USD
CY2016Q4	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	5800000	USD
CY2016Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	310000	USD
CY2016Q4	us-gaap	Notes Payable NotesPayable	135000	USD
CY2016	us-gaap	Interest Expense Other InterestExpenseOther	6000	USD
CY2015	us-gaap	Interest Expense Other InterestExpenseOther	9000	USD
CY2016	us-gaap	Interest Expense Debt InterestExpenseDebt	3818000	USD
CY2015	us-gaap	Interest Expense Debt InterestExpenseDebt	4153000	USD
CY2016	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	77024000	shares
CY2015	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	30581000	shares
CY2016Q2	nwbo	Stock Outstanding Percentage Limit StockOutstandingPercentageLimit	0.2	pure
CY2016Q1	nwbo	Procees From Sale Of Availiable Securities Gross ProceesFromSaleOfAvailiableSecuritiesGross	10000000	USD
CY2016Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	9200000	USD
CY2016Q2	nwbo	Deemed Dividend Related To Warrant Modification DeemedDividendRelatedToWarrantModification	2600000	USD
CY2016Q3	nwbo	Class Of Warrant Or Right Increase Decrease Warrant Exercise Value ClassOfWarrantOrRightIncreaseDecreaseWarrantExerciseValue	3000000	USD
CY2016Q3	nwbo	Class Of Warrant Or Rightwarrant Issue During Period ClassOfWarrantOrRightwarrantIssueDuringPeriod	1111111	shares
CY2016Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.45
CY2016Q3	nwbo	Class Of Warrant Or Rightwarrant Term ClassOfWarrantOrRightwarrantTerm	P5Y
CY2016	dei	Document Type DocumentType	10-K
CY2016	dei	Amendment Flag AmendmentFlag	false
CY2016	dei	Document Period End Date DocumentPeriodEndDate	2016-12-31
CY2016	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
CY2016	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2016	dei	Entity Registrant Name EntityRegistrantName	NORTHWEST BIOTHERAPEUTICS INC
CY2016	dei	Entity Central Index Key EntityCentralIndexKey	0001072379
CY2016	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2016	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2016	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2016	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2016	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2016Q2	dei	Entity Public Float EntityPublicFloat	32379666	USD
CY2016	dei	Trading Symbol TradingSymbol	NWBO
CY2017Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	186061822	shares
CY2016Q4	nwbo	Current Assets Less Payables CurrentAssetsLessPayables	68500000	USD
CY2016Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	44559000	USD
CY2015Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	45681000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	40000000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	40000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	157028270	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	157028270	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	95858087	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	95858087	shares
CY2016	us-gaap	Legal Fees LegalFees	8941000	USD
CY2015	us-gaap	Legal Fees LegalFees	6577000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	-35027000	USD
CY2015	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	81662000	USD
CY2015	nwbo	Stock Issued During Period Value Redeemable Securities Settlement StockIssuedDuringPeriodValueRedeemableSecuritiesSettlement	299000	USD
CY2015	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	6500000	USD
CY2015	nwbo	Stock Issued During Period Value Conversion Of Accrued Interest StockIssuedDuringPeriodValueConversionOfAccruedInterest	387000	USD
CY2015	nwbo	Stock Issued During Period Value Proceeds From Warrants Exercises StockIssuedDuringPeriodValueProceedsFromWarrantsExercises	7430000	USD
CY2015	nwbo	Adjustments To Additional Paid In Capital Reclassification AdjustmentsToAdditionalPaidInCapitalReclassification	264000	USD
CY2015	nwbo	Stock Issued During Period Value Issued For Non Cash Consideration StockIssuedDuringPeriodValueIssuedForNonCashConsideration	521000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	57000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	67000	USD
CY2016	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
CY2015	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	57000	USD
CY2016	us-gaap	Restructuring Costs RestructuringCosts	0	USD
CY2015	us-gaap	Restructuring Costs RestructuringCosts	-53000	USD
CY2016	us-gaap	Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	5218000	USD
CY2015	us-gaap	Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	29786000	USD
CY2016	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	5450000	USD
CY2015	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
CY2016	us-gaap	Increase Decrease In Notes Payable Related Parties IncreaseDecreaseInNotesPayableRelatedParties	260000	USD
CY2015	us-gaap	Increase Decrease In Notes Payable Related Parties IncreaseDecreaseInNotesPayableRelatedParties	1400000	USD
CY2016	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	USD
CY2015	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	1400000	USD
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-6659000	USD
CY2016Q4	us-gaap	Debt Default Longterm Debt Amount DebtDefaultLongtermDebtAmount	5200000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	204106000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	180927000	USD
CY2016Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	14911000	USD
CY2015Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	12661000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	17106000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	24759000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	236123000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	218347000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	236123000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	218347000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2015Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.340	pure
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.340	pure
CY2016	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.018	pure
CY2015	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.054	pure
CY2016Q4	us-gaap	Liabilities Fair Value Disclosure Recurring LiabilitiesFairValueDisclosureRecurring	10062000	USD
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.028	pure
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.026	pure
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.222	pure
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.478	pure
CY2016	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0	pure
CY2015	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0	pure
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-11160000	USD
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-41583000	USD
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1427000	USD
CY2016	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-17776000	USD
CY2015	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-48242000	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2016	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt">Prior Period Reclassifications</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt">Certain prior period amounts that were combined in the December 31, 2015 consolidated financial statements have been reclassified for comparability with the December 31, 2016 presentation. These reclassifications had no effect on previously reported net loss.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	44742000	USD
CY2016	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt">Use of Estimates</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><i><font style="FONT-SIZE: 10pt">  </font></i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt">In preparing financial statements in conformity with U.S. GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of expenses during the reporting period. Due to inherent uncertainty involved in making estimates, actual results reported in future periods may be affected by changes in these estimates. On an ongoing basis, the Company evaluates its estimates and assumptions. These estimates and assumptions include valuing equity securities in share-based payment arrangements, estimating the fair value of financial instruments recorded as derivative liabilities, useful lives of depreciable assets and whether impairment charges may apply, and the fair value of environmental remediation liabilities.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	27982000	USD
CY2016Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	10062000	USD
CY2015	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	521000	USD
CY2015	nwbo	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Warrant Exercised For Cash FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisWarrantExercisedForCash	264000	USD
CY2015	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	299000	USD
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.023	pure
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.0	pure
CY2016	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Issues FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues	10131000	USD
CY2016	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales	415000	USD
CY2016	nwbo	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Warrant Granted FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisWarrantGranted	5317000	USD
CY2016	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	USD
CY2015	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	USD
CY2016	nwbo	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements Related To Sharesettled Debt FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlementsRelatedToSharesettledDebt	5680000	USD
CY2016	nwbo	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements Related To Conversion Of Sharesettled Debt FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlementsRelatedToConversionOfSharesettledDebt	480000	USD
CY2016	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-5189000	USD
CY2015	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	USD
CY2016Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	507500000	USD
CY2016Q4	nwbo	Deferred Tax Assets Tax Credit Carry Forward Unused Research And Development DeferredTaxAssetsTaxCreditCarryForwardUnusedResearchAndDevelopment	14900000	USD
CY2015Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1235000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	685000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	6871000	USD
CY2015Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	23048000	USD
CY2016	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	300000	USD
CY2015	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	300000	USD
CY2012Q3	nwbo	Office Space Taken Under Lease Agreement OfficeSpaceTakenUnderLeaseAgreement	7,097 square feet
CY2016Q1	nwbo	Office Space Taken Under Lease Agreement OfficeSpaceTakenUnderLeaseAgreement	505 square feet
CY2014Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	29385	shares
CY2015Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	27267	shares
CY2016Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	58278	shares
CY2016	nwbo	Class Of Warrant Or Right Granted In Registered Direct Offering ClassOfWarrantOrRightGrantedInRegisteredDirectOffering	14485	shares
CY2016	nwbo	Number Of Warrants Granted To Cognate NumberOfWarrantsGrantedToCognate	35504	shares
CY2016	nwbo	Class Of Warrant Or Rightnon Cognate Warrants Cancelled ClassOfWarrantOrRightnonCognateWarrantsCancelled	37147	shares
CY2016	nwbo	Number Of Warrants Warrants Exercised For Cash NumberOfWarrantsWarrantsExercisedForCash	15357	shares
CY2015	nwbo	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired	2431	shares
CY2015	nwbo	Class Of Warrant Or Right Owed To Cognate ClassOfWarrantOrRightOwedToCognate	62	shares
CY2015	nwbo	Number Of Warrants Warrants Exercised On Cashless Basis NumberOfWarrantsWarrantsExercisedOnCashlessBasis	304	shares
CY2015	nwbo	Number Of Warrants Warrants Exercised For Cash NumberOfWarrantsWarrantsExercisedForCash	1678	shares
CY2015	nwbo	Number Of Warrants Adjustment Related To Prior Issued Warrants NumberOfWarrantsAdjustmentRelatedToPriorIssuedWarrants	280	shares
CY2016	nwbo	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired	1761	shares
CY2014Q4	nwbo	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	4.72
CY2015Q4	nwbo	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	4.40
CY2016Q4	nwbo	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	1.78
CY2015	nwbo	Class Of Warrant Or Right Granted Weighted Average Exercise Price ClassOfWarrantOrRightGrantedWeightedAverageExercisePrice	4.51
CY2015	nwbo	Weighted Average Exercise Price Exercised For Cash WeightedAverageExercisePriceExercisedForCash	4.25
CY2015	nwbo	Class Of Warrant Or Right Expired Weighted Average Exercise Price ClassOfWarrantOrRightExpiredWeightedAverageExercisePrice	4.82
CY2016	nwbo	Class Of Warrant Or Right Granted In Registerd Direct Offering Weighted Average Exercise Price ClassOfWarrantOrRightGrantedInRegisterdDirectOfferingWeightedAverageExercisePrice	2.70
CY2016	nwbo	Class Of Warrants Or Rights Granted To Congnate Weighted Average Exercise Price ClassOfWarrantsOrRightsGrantedToCongnateWeightedAverageExercisePrice	0.69
CY2016	nwbo	Class Of Warrant Or Right To Cognate Cancelled Weighted Average Exercise Price ClassOfWarrantOrRightToCognateCancelledWeightedAverageExercisePrice	0.35
CY2016	nwbo	Weighted Average Exercise Price Exercised For Cash WeightedAverageExercisePriceExercisedForCash	0.53
CY2016	nwbo	Class Of Warrant Or Right Granted Weighted Average Exercise Price ClassOfWarrantOrRightGrantedWeightedAverageExercisePrice	0.43
CY2016	nwbo	Class Of Warrant Or Right Expired Weighted Average Exercise Price ClassOfWarrantOrRightExpiredWeightedAverageExercisePrice	9.36
CY2015	nwbo	Class Of Warrant Or Right Granted ClassOfWarrantOrRightGranted	1953	shares
CY2016	nwbo	Class Of Warrant Or Right Granted ClassOfWarrantOrRightGranted	35287	shares
CY2016Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	32561000	USD
CY2016Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	310000	USD
CY2016Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	540000	USD
CY2016Q4	us-gaap	Long Term Debt LongTermDebt	31711000	USD
CY2015Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	925000	USD
CY2016Q4	us-gaap	Warrants Not Settleable In Cash Fair Value Disclosure WarrantsNotSettleableInCashFairValueDisclosure	4200000	USD
CY2015Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	888187	shares
CY2015Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3700000	USD
CY2015Q1	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	80068	shares
CY2015Q1	nwbo	Adjustments To Additional Paid In Capital Redeemable Securities Settlement Value AdjustmentsToAdditionalPaidInCapitalRedeemableSecuritiesSettlementValue	300000	USD
CY2015Q1	nwbo	Stock Issued During Period Shares Cashless Exercise Of Warrants StockIssuedDuringPeriodSharesCashlessExerciseOfWarrants	385000	shares
CY2015Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	500000	USD
CY2015Q2	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	3851351	shares
CY2015Q2	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	5405405	shares
CY2015Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	7.40
CY2015Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	40000000	USD
CY2015Q2	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	1554054	shares
CY2015Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	11500000	USD
CY2015Q2	us-gaap	Sale Of Stock Transaction Date SaleOfStockTransactionDate	2015-04-08
CY2015Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	28500000	USD
CY2015	nwbo	Issuance Of Common Stock And Warrants In Connection Conversion Of Accounts Payable IssuanceOfCommonStockAndWarrantsInConnectionConversionOfAccountsPayable	3751000	USD
CY2016	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	488000	USD
CY2015	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	USD
CY2016	nwbo	Accrued Exit Fee Incurred From Mortgage Loan AccruedExitFeeIncurredFromMortgageLoan	0	USD
CY2015	nwbo	Accrued Exit Fee Incurred From Mortgage Loan AccruedExitFeeIncurredFromMortgageLoan	51000	USD
CY2016	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	825000	USD
CY2015	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	264000	USD
CY2016	nwbo	Reclassification Of Warrant Liabilities Related To Cashless Warrants Exercise ReclassificationOfWarrantLiabilitiesRelatedToCashlessWarrantsExercise	0	USD
CY2015	nwbo	Reclassification Of Warrant Liabilities Related To Cashless Warrants Exercise ReclassificationOfWarrantLiabilitiesRelatedToCashlessWarrantsExercise	521000	USD
CY2016	nwbo	Tax Receivable Related To Uk Facility TaxReceivableRelatedToUkFacility	0	USD
CY2015	nwbo	Tax Receivable Related To Uk Facility TaxReceivableRelatedToUkFacility	537000	USD
CY2015Q2	us-gaap	Sale Of Stock Transaction Date SaleOfStockTransactionDate	2015-05-01
CY2015Q2	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	4500000	USD
CY2015Q2	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	701033	shares
CY2015Q2	nwbo	Stock Issued During Period Exercise Of Warrants StockIssuedDuringPeriodExerciseOfWarrants	723422	shares
CY2015Q2	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3100000	USD
CY2015Q2	nwbo	Stock Issued During Period Shares Extinguishment Of Warrant Liabilities StockIssuedDuringPeriodSharesExtinguishmentOfWarrantLiabilities	9200	shares
CY2015Q2	nwbo	Stock Issued During Period Value Extinguishment Of Warrant Liabilities StockIssuedDuringPeriodValueExtinguishmentOfWarrantLiabilities	60000	USD
CY2015Q3	nwbo	Stock Issued During Period Shares Exercise Of Warrant StockIssuedDuringPeriodSharesExerciseOfWarrant	116675	shares
CY2015Q3	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	800000	USD
CY2015Q3	nwbo	Stock Issued During Period Shares Extinguishment Of Warrant Liabilities StockIssuedDuringPeriodSharesExtinguishmentOfWarrantLiabilities	57500	shares
CY2015Q3	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	200000	USD
CY2015Q3	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	322502	shares
CY2016	nwbo	Warrants Issued During Period WarrantsIssuedDuringPeriod	49827000	shares
CY2015Q4	nwbo	Warrant Issuable WarrantIssuable	3812555	shares
CY2016Q3	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	22500000	USD
CY2016	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	2500000	USD
CY2016Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.00
CY2016Q3	nwbo	Class Of Warrants Or Rights Number Of Replacement Warrants Outstanding ClassOfWarrantsOrRightsNumberOfReplacementWarrantsOutstanding	4300000	shares
CY2016Q3	nwbo	Fair Value Of Replacement Warrants FairValueOfReplacementWarrants	403000	USD
CY2016	nwbo	Return Of Common Stock And Warrants ReturnOfCommonStockAndWarrants	8000	USD
CY2015	nwbo	Return Of Common Stock And Warrants ReturnOfCommonStockAndWarrants	0	USD
CY2016	nwbo	Extinguishment Of Shares Payable ExtinguishmentOfSharesPayable	22539000	USD
CY2015	nwbo	Extinguishment Of Shares Payable ExtinguishmentOfSharesPayable	0	USD
CY2016	nwbo	Extinguishment Of Derivative Liabilities ExtinguishmentOfDerivativeLiabilities	10131000	USD
CY2015	nwbo	Extinguishment Of Derivative Liabilities ExtinguishmentOfDerivativeLiabilities	0	USD
CY2016	nwbo	Issuance Of Warrants In Conjunction With Demand Notes IssuanceOfWarrantsInConjunctionWithDemandNotes	0	USD
CY2015	nwbo	Issuance Of Warrants In Conjunction With Demand Notes IssuanceOfWarrantsInConjunctionWithDemandNotes	57000	USD
CY2016	us-gaap	Stock Issued1 StockIssued1	28000	USD
CY2015	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2016	nwbo	Issuance Of Common Stock And Warrants In Connection Conversion Of Accounts Payable IssuanceOfCommonStockAndWarrantsInConnectionConversionOfAccountsPayable	0	USD
CY2016	nwbo	Redeemable Security Settlement RedeemableSecuritySettlement	0	USD
CY2015	nwbo	Redeemable Security Settlement RedeemableSecuritySettlement	299000	USD
CY2016	us-gaap	Notes Assumed1 NotesAssumed1	310000	USD
CY2015	us-gaap	Notes Assumed1 NotesAssumed1	0	USD
CY2016	nwbo	Offering Costs Payable OfferingCostsPayable	800000	USD
CY2015	nwbo	Offering Costs Payable OfferingCostsPayable	0	USD
CY2016Q4	us-gaap	Minimum Lease Payments Sale Leaseback Transactions Within One Year MinimumLeasePaymentsSaleLeasebackTransactionsWithinOneYear	557000	USD
CY2016Q4	us-gaap	Minimum Lease Payments Sale Leaseback Transactions Within Two Years MinimumLeasePaymentsSaleLeasebackTransactionsWithinTwoYears	120000	USD
CY2016Q4	us-gaap	Minimum Lease Payments Sale Leaseback Transactions MinimumLeasePaymentsSaleLeasebackTransactions	677000	USD
CY2016Q4	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	321000	USD
CY2015	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-15676000	USD
CY2016	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-17891000	USD
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-85861000	USD
CY2015	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-114741000	USD
CY2016	nwbo	Effective Income Tax Rate Reconciliation Deduction Cancellation Of Warrants EffectiveIncomeTaxRateReconciliationDeductionCancellationOfWarrants	-0.166	pure
CY2015	nwbo	Effective Income Tax Rate Reconciliation Deduction Cancellation Of Warrants EffectiveIncomeTaxRateReconciliationDeductionCancellationOfWarrants	0.0	pure
CY2016	nwbo	Effective Income Tax Rate Reconciliation Deduction Cancellation Of Shares EffectiveIncomeTaxRateReconciliationDeductionCancellationOfShares	-0.078	pure
CY2015	nwbo	Effective Income Tax Rate Reconciliation Deduction Cancellation Of Shares EffectiveIncomeTaxRateReconciliationDeductionCancellationOfShares	0.0	pure
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.027	pure
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0	pure
CY2016	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	1457000	USD
CY2015	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	0	USD
CY2016	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-5680000	USD
CY2015	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	USD
CY2016	nwbo	Share Payments Due To Related Parties Value SharePaymentsDueToRelatedPartiesValue	8885000	USD
CY2015	nwbo	Weighted Average Exercise Pricewarrants Exercised On Cashless Basis WeightedAverageExercisePricewarrantsExercisedOnCashlessBasis	3.96
CY2015	nwbo	Weighted Average Price Of Warrant Adjustment Due To Price Reset WeightedAveragePriceOfWarrantAdjustmentDueToPriceReset	3.35
CY2015	nwbo	Weighted Average Exercise Price Adjustment Related To Prior Issued Warrants WeightedAverageExercisePriceAdjustmentRelatedToPriorIssuedWarrants	4.41
CY2016	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.77
CY2015	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.48
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.076	pure
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.058	pure
CY2015	nwbo	Stock Issued During Period Value Conversion Of Accounts Payable To Common Stock StockIssuedDuringPeriodValueConversionOfAccountsPayableToCommonStock	3751000	USD
CY2016	nwbo	Stock Issued During Period Value Conversion Of Accounts Payable To Common Stock StockIssuedDuringPeriodValueConversionOfAccountsPayableToCommonStock	28000	USD
CY2016	nwbo	Cash Cash Equivalents And Shortterm Investmentsperiod Increase Decrease CashCashEquivalentsAndShorttermInvestmentsperiodIncreaseDecrease	-16177000	USD
CY2015	nwbo	Cash Cash Equivalents And Shortterm Investmentsperiod Increase Decrease CashCashEquivalentsAndShorttermInvestmentsperiodIncreaseDecrease	7033000	USD
CY2014Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	16015000	USD
CY2016	nwbo	Issuance Of Common Stock And Warrants For Conversion Of Debt And Accrued Interest IssuanceOfCommonStockAndWarrantsForConversionOfDebtAndAccruedInterest	1869000	USD
CY2015	nwbo	Issuance Of Common Stock And Warrants For Conversion Of Debt And Accrued Interest IssuanceOfCommonStockAndWarrantsForConversionOfDebtAndAccruedInterest	6887000	USD
CY2016	nwbo	Sharebased Compensation Aggregate Charges For Interest Associated With Accretion Of Our Convertible Notes Discount Net SharebasedCompensationAggregateChargesForInterestAssociatedWithAccretionOfOurConvertibleNotesDiscountNet	5800000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	720000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	692000	USD
CY2015Q4	nwbo	Property Plant And Equipment Net Including Construction In Progress PropertyPlantAndEquipmentNetIncludingConstructionInProgress	46157000	USD
CY2016Q4	nwbo	Property Plant And Equipment Net Including Construction In Progress PropertyPlantAndEquipmentNetIncludingConstructionInProgress	44874000	USD
CY2015	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	3389000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	40765000	USD
CY2016	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	111078000	shares
CY2015	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	77713000	shares

Files In Submission

Name	View Source	Status
0001144204-17-020754-index-headers.html	Edgar Link	pending
0001144204-17-020754-index.html	Edgar Link	pending
0001144204-17-020754.txt	Edgar Link	pending
0001144204-17-020754-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
nwbo-20161231.xml	Edgar Link	completed
nwbo-20161231.xsd	Edgar Link	pending
nwbo-20161231_cal.xml	Edgar Link	unprocessable
nwbo-20161231_def.xml	Edgar Link	unprocessable
nwbo-20161231_lab.xml	Edgar Link	unprocessable
nwbo-20161231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v464066_10k.htm	Edgar Link	pending
v464066_ex21-1.htm	Edgar Link	pending
v464066_ex23-1.htm	Edgar Link	pending
v464066_ex31-1.htm	Edgar Link	pending
v464066_ex32-1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NWBO
NORTHWEST BIOTHERAPEUTICS INC Stock $nwbo

2016 Q4 Form 10-K Financial Statement

#000114420417020754 Filed on April 17, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NWBO NORTHWEST BIOTHERAPEUTICS INC Stock $nwbo

2016 Q4 Form 10-K Financial Statement

#000114420417020754 Filed on April 17, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NWBO
NORTHWEST BIOTHERAPEUTICS INC Stock $nwbo